Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
XFOR
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -24.6%
XFOR
X4 Pharmaceuticals, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
inducement
pharmaceuticals
trading
awards
2023
2019
plan
results
announced
last
after
high
rating
compared
period
nyse
equity
listing
rule
StonvexStonvexStonvexStonvex